Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,014 public trials 2,030 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

NCT00136903

Conditions
Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • St. Francis Hospital Indianapolis, Indiana, United States
  • Kansas City Cancer Centers - BMT Kansas City, Missouri, United States
  • The Cancer Center at Hackensack University Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

Optimising Renal Outcome in Myeloma Renal Failure

NCT02424851

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations
  • Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom
  • Heartlands Hospitals Birmingham, United Kingdom
  • Kent & Canterbury Hospital Canterbury, United Kingdom
  • St Helier Hospital Epsom, United Kingdom
View Trial Details
Completed

Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients

NCT04065789

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Haemek Medical Center Afula, Israel
  • Barzilai Medical Center Ashkelon, Israel
  • Soroka Medical Center Beersheba, Israel
  • Bnai-Zion Medical Center Haifa, Israel
View all 14 locations
View Trial Details
Completed

Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)

NCT01724879

Conditions
Chromosome Aberrations, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Robert Bosch Krankenhaus Stuttgart, Baden-Wurttemberg, Germany
  • Klinikum der Universität Regensburg Regensburg, Bavaria, Germany
  • University Hospital of Frankfurt, Medical Dept. II Frankfurt am Main, Hesse, Germany
  • Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
View all 22 locations
View Trial Details
Completed

A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6

NCT03255096

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Weill Cornell Medical College New York, United States
  • Levine Cancer Institute - Blythe Charlotte, North Carolina, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT02968563

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Ambulante Krebszentrum Schaubstraße Frankfurt (Oder), Brandenburg, Germany
  • Hämatologische-onkologische Gem.-Praxis Dres. Brudler-Heinrich-Bangerter, Augsburg Augsburg, Germany
  • Uniklinik Koln Cologne, Germany
  • Internistische Gemeinschaftspraxis Dres. Schliesser-Käbisch-Weber, Gießen Giessen, Germany
View all 14 locations
View Trial Details

Related conditions